Robust p53 Stabilization Is Dispensable for Its Activation and Tumor Suppressor Function.

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• p53 protein levels increase dramatically upon DNA damage for activation.
• The necessity of this robust stabilization for tumor suppression is not fully understood.
• Acetylation is a key post-translational modification regulating p53 activity.

Purpose of the Study:

• To investigate if p53's tumor suppressor functions can be activated independently of robust stabilization.
• To explore the therapeutic potential of mimicking p53 C-terminal acetylation.

Main Methods:

• Generated a mutant p53 mouse model with C-terminal lysine residues mutated to glutamine (K to Q) to mimic constitutive acetylation.
• Analyzed p53 target gene activation, p53 levels, and tumor suppression in various models.
• Utilized a pancreatic ductal adenocarcinoma (PDAC) mouse model with K-Ras mutation.

Main Results:

• The acetylation-mimicking p53 mutant mice showed normal postnatal development but premature death due to anemia.
• In vivo, the mutant p53 induced p53 target gene activation without increasing p53 levels.
• Expression of the acetylation-mimicking p53 mutant suppressed K-Ras-induced PDAC development.

Conclusions:

• p53-mediated transcriptional function and tumor suppression can be achieved independently of robust p53 stabilization.
• Mimicking p53 acetylation provides a novel therapeutic approach for cancer treatment.
• Low basal p53 protein levels play a crucial role in p53 activation and tumor suppression.